Literature DB >> 21971049

Autotaxin regulates vascular development via multiple lysophosphatidic acid (LPA) receptors in zebrafish.

Hiroshi Yukiura1, Kotaro Hama1, Keita Nakanaga1, Masayuki Tanaka2, Yoichi Asaoka3, Shinichi Okudaira1, Naoaki Arima1, Asuka Inoue1, Takafumi Hashimoto1, Hiroyuki Arai4, Atsuo Kawahara5, Hiroshi Nishina3, Junken Aoki6.   

Abstract

Autotaxin (ATX) is a multifunctional ecto-type phosphodiesterase that converts lysophospholipids, such as lysophosphatidylcholine, to lysophosphatidic acid (LPA) by its lysophospholipase D activity. LPA is a lipid mediator with diverse biological functions, most of which are mediated by G protein-coupled receptors specific to LPA (LPA1-6). Recent studies on ATX knock-out mice revealed that ATX has an essential role in embryonic blood vessel formation. However, the underlying molecular mechanisms remain to be solved. A data base search revealed that ATX and LPA receptors are conserved in wide range of vertebrates from fishes to mammals. Here we analyzed zebrafish ATX (zATX) and LPA receptors both biochemically and functionally. zATX, like mammalian ATX, showed lysophospholipase D activity to produce LPA. In addition, all zebrafish LPA receptors except for LPA5a and LPA5b were found to respond to LPA. Knockdown of zATX in zebrafish embryos by injecting morpholino antisense oligonucleotides (MOs) specific to zATX caused abnormal blood vessel formation, which has not been observed in other morphant embryos or mutants with vascular defects reported previously. In ATX morphant embryos, the segmental arteries sprouted normally from the dorsal aorta but stalled in midcourse, resulting in aberrant vascular connection around the horizontal myoseptum. Similar vascular defects were not observed in embryos in which each single LPA receptor was attenuated by using MOs. Interestingly, similar vascular defects were observed when both LPA1 and LPA4 functions were attenuated by using MOs and/or a selective LPA receptor antagonist, Ki16425. These results demonstrate that the ATX-LPA-LPAR axis is a critical regulator of embryonic vascular development that is conserved in vertebrates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21971049      PMCID: PMC3243515          DOI: 10.1074/jbc.M111.301093

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  LPA-producing enzyme PA-PLA₁α regulates hair follicle development by modulating EGFR signalling.

Authors:  Asuka Inoue; Naoaki Arima; Jun Ishiguro; Glenn D Prestwich; Hiroyuki Arai; Junken Aoki
Journal:  EMBO J       Date:  2011-08-19       Impact factor: 11.598

2.  Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior.

Authors:  J J Contos; N Fukushima; J A Weiner; D Kaushal; J Chun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

3.  Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase.

Authors:  Akira Tokumura; Eiji Majima; Yuko Kariya; Kyoko Tominaga; Kentaro Kogure; Katsuhiko Yasuda; Kenji Fukuzawa
Journal:  J Biol Chem       Date:  2002-08-09       Impact factor: 5.157

4.  Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.

Authors:  Hideo Ohta; Koichi Sato; Naoya Murata; Alatangaole Damirin; Enkhzol Malchinkhuu; Junko Kon; Takao Kimura; Masayuki Tobo; Yuji Yamazaki; Tomoko Watanabe; Mikio Yagi; Motoko Sato; Rika Suzuki; Hideko Murooka; Teruyuki Sakai; Tsuyoshi Nishitoba; Dong-Soon Im; Hiromi Nochi; Koichi Tamoto; Hideaki Tomura; Fumikazu Okajima
Journal:  Mol Pharmacol       Date:  2003-10       Impact factor: 4.436

5.  Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate.

Authors:  Timothy Clair; Junken Aoki; Eunjin Koh; Russell W Bandle; Suk Woo Nam; Malgorzata M Ptaszynska; Gordon B Mills; Elliott Schiffmann; Lance A Liotta; Mary L Stracke
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

6.  Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.

Authors:  Kotaro Hama; Junken Aoki; Masahiro Fukaya; Yasuhiro Kishi; Teruyuki Sakai; Rika Suzuki; Hideo Ohta; Takao Yamori; Masahiko Watanabe; Jerold Chun; Hiroyuki Arai
Journal:  J Biol Chem       Date:  2004-01-26       Impact factor: 5.157

7.  Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2).

Authors:  James J A Contos; Isao Ishii; Nobuyuki Fukushima; Marcy A Kingsbury; Xiaoqin Ye; Shuji Kawamura; Joan Heller Brown; Jerold Chun
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

8.  Analysis of a zebrafish VEGF receptor mutant reveals specific disruption of angiogenesis.

Authors:  Hinrich Habeck; Jörg Odenthal; Brigitte Walderich; Hans Maischein; Stefan Schulte-Merker
Journal:  Curr Biol       Date:  2002-08-20       Impact factor: 10.834

9.  A novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method.

Authors:  Tatsuya Kishimoto; Takeshi Matsuoka; Shigeyuki Imamura; Koji Mizuno
Journal:  Clin Chim Acta       Date:  2003-07-01       Impact factor: 3.786

10.  Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.

Authors:  Makiko Umezu-Goto; Yasuhiro Kishi; Akitsu Taira; Kotaro Hama; Naoshi Dohmae; Koji Takio; Takao Yamori; Gordon B Mills; Keizo Inoue; Junken Aoki; Hiroyuki Arai
Journal:  J Cell Biol       Date:  2002-07-15       Impact factor: 10.539

View more
  37 in total

Review 1.  Lipid phosphate phosphatases and their roles in mammalian physiology and pathology.

Authors:  Xiaoyun Tang; Matthew G K Benesch; David N Brindley
Journal:  J Lipid Res       Date:  2015-03-26       Impact factor: 5.922

Review 2.  Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression.

Authors:  Lorenzo Federico; Kang Jin Jeong; Christopher P Vellano; Gordon B Mills
Journal:  J Lipid Res       Date:  2015-05-14       Impact factor: 5.922

Review 3.  Lysophosphatidic acid signalling in development.

Authors:  Xiaoyan Sheng; Yun C Yung; Allison Chen; Jerold Chun
Journal:  Development       Date:  2015-04-15       Impact factor: 6.868

4.  Autotaxin/ENPP2 regulates oligodendrocyte differentiation in vivo in the developing zebrafish hindbrain.

Authors:  Larra W Yuelling; Christopher T Waggener; Fatemah S Afshari; James A Lister; Babette Fuss
Journal:  Glia       Date:  2012-07-20       Impact factor: 7.452

5.  X-chromosome association studies of congenital heart defects.

Authors:  A J Agopian; Thanh T Hoang; Elizabeth Goldmuntz; Hakon Hakonarson; Fadi I Musfee; Laura E Mitchell
Journal:  Am J Med Genet A       Date:  2019-11-15       Impact factor: 2.802

Review 6.  Comparative analyses of lysophosphatidic acid receptor-mediated signaling.

Authors:  Nobuyuki Fukushima; Shoichi Ishii; Toshifumi Tsujiuchi; Nao Kagawa; Kazutaka Katoh
Journal:  Cell Mol Life Sci       Date:  2015-03-04       Impact factor: 9.261

7.  Lysophosphatidic acid produced by hen egg white lysophospholipase D induces vascular development on extraembryonic membranes.

Authors:  Junichi Morishige; Yoshihiro Uto; Hitoshi Hori; Kiyoshi Satouchi; Tanihiro Yoshiomoto; Akira Tokumura
Journal:  Lipids       Date:  2013-02-06       Impact factor: 1.880

8.  Regulation of Lysophosphatidic Acid Metabolism and Signaling by Lipoproteins.

Authors:  Andrew J Morris; Susan S Smyth
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-10       Impact factor: 8.311

Review 9.  Lipid phosphate phosphatase (LPP3) and vascular development.

Authors:  H Ren; M Panchatcharam; P Mueller; D Escalante-Alcalde; A J Morris; S S Smyth
Journal:  Biochim Biophys Acta       Date:  2012-07-24

10.  Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin.

Authors:  Russell R Braeuer; Maya Zigler; Takafumi Kamiya; Andrey S Dobroff; Li Huang; Woonyoung Choi; David J McConkey; Einav Shoshan; Aaron K Mobley; Renduo Song; Avraham Raz; Menashe Bar-Eli
Journal:  Cancer Res       Date:  2012-09-17       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.